FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1864088770> ?p ?o ?g. }

• W1864088770 endingPage "475" @default.
• W1864088770 startingPage "468" @default.
• W1864088770 abstract "The prevalence of Helicobacter pylori increases with age. However, data regarding the effects of anti-H. pylori treatments in the elderly are very scarce.To evaluate the effect of three lansoprazole-based, 7 day, triple-therapy regimens on H. pylori eradication rates, symptomatology, chronic gastritis activity and serological markers of H. pylori infection in elderly subjects, we studied 150 symptomatic patients over 60 years of age with H. pylori-positive duodenal ulcer (DU, n = 34), gastric ulcer (GU, n= 19) or chronic gastritis (CG, n = 97). Patients were consecutively treated with one of the following regimens: (A) lansoprazole (LNS) 30 mg b.i.d. + clarithromycin (CLR) 250 mg b.i.d. + metronidazole (MTR) 250 mg q.i.d.; (B) LNS 30mg b.i.d. + amoxycillin (AMOX) 1 g b.i.d. + MTR 250 mg q.i.d.; and (C) LNS 30 mg b.i.d. + CLR 250 mg b.i.d. + AMOX 1 g b.i.d.Two months after therapy, the eradication rates of the three treatments, expressed using both intention-to-treat and per-protocol analyses were, respectively; group A, 86 and 91.5%; group B, 80 and 87%; group C, 82 and 89.1%. After therapy, a significant reduction in epigastric pain (P<0.001), heartburn (P=0.02), dyspepsia (P<0.001) and vomiting (P< 0.005) was observed independently of the success of H. pylori eradication. A significantly higher percentage of asymptomatic patients were in the GU-DU group than in CG group (87.7 vs 70.0%, P= 0.032). After therapy, 33 subjects still suffered from symptoms. Persistence of symptoms was significantly associated with an endoscopic diagnosis of oesophagitis and not with H. pylori infection. Patients cured of H. pylori infection showed a significant decrease in the histological activity of both antral and body gastritis (P< 0.0001), a significant drop in immunoglobulin (Ig) G anti-H. pylori antibodies (P< 0.0001) and pepsinogen (PG) C (P<0.0001) and an increase in the PGA/PGC ratio (P<0.0001).The 7 day, lansoprazole-based triple therapy was well tolerated and highly effective in the cure of H. pylori infection, the reduction of symptoms, chronic gastritis activity and serum levels of IgG anti-H. pylori antibodies and PGC. Persistence of symptoms after therapy was significantly higher in CG than GU and DU patients and was significantly associated with oesophagitis." @default.
• W1864088770 created "2016-06-24" @default.
• W1864088770 creator A5001722887 @default.
• W1864088770 creator A5003505640 @default.
• W1864088770 creator A5004257280 @default.
• W1864088770 creator A5013907113 @default.
• W1864088770 creator A5016955453 @default.
• W1864088770 creator A5019589605 @default.
• W1864088770 creator A5021006462 @default.
• W1864088770 creator A5030427327 @default.
• W1864088770 creator A5044207347 @default.
• W1864088770 creator A5056912422 @default.
• W1864088770 creator A5065550959 @default.
• W1864088770 date "2003-12-10" @default.
• W1864088770 modified "2023-09-27" @default.
• W1864088770 title "Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients" @default.
• W1864088770 cites W119422958 @default.
• W1864088770 cites W1562908575 @default.
• W1864088770 cites W1977458972 @default.
• W1864088770 cites W1991415057 @default.
• W1864088770 cites W1999768369 @default.
• W1864088770 cites W2007123105 @default.
• W1864088770 cites W2020358242 @default.
• W1864088770 cites W2021299387 @default.
• W1864088770 cites W2023345830 @default.
• W1864088770 cites W2027818069 @default.
• W1864088770 cites W2041996016 @default.
• W1864088770 cites W2065160025 @default.
• W1864088770 cites W2071205011 @default.
• W1864088770 cites W2074095579 @default.
• W1864088770 cites W2080009414 @default.
• W1864088770 cites W2097688014 @default.
• W1864088770 cites W2121198981 @default.
• W1864088770 cites W2134002758 @default.
• W1864088770 cites W2589506919 @default.
• W1864088770 cites W4237403611 @default.
• W1864088770 cites W2046906124 @default.
• W1864088770 doi "https://doi.org/10.1046/j.1440-1746.1999.01893.x" @default.
• W1864088770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10355512" @default.
• W1864088770 hasPublicationYear "2003" @default.
• W1864088770 type Work @default.
• W1864088770 sameAs 1864088770 @default.
• W1864088770 citedByCount "37" @default.
• W1864088770 countsByYear W18640887702012 @default.
• W1864088770 countsByYear W18640887702013 @default.
• W1864088770 countsByYear W18640887702014 @default.
• W1864088770 countsByYear W18640887702016 @default.
• W1864088770 countsByYear W18640887702019 @default.
• W1864088770 countsByYear W18640887702020 @default.
• W1864088770 countsByYear W18640887702021 @default.
• W1864088770 crossrefType "journal-article" @default.
• W1864088770 hasAuthorship W1864088770A5001722887 @default.
• W1864088770 hasAuthorship W1864088770A5003505640 @default.
• W1864088770 hasAuthorship W1864088770A5004257280 @default.
• W1864088770 hasAuthorship W1864088770A5013907113 @default.
• W1864088770 hasAuthorship W1864088770A5016955453 @default.
• W1864088770 hasAuthorship W1864088770A5019589605 @default.
• W1864088770 hasAuthorship W1864088770A5021006462 @default.
• W1864088770 hasAuthorship W1864088770A5030427327 @default.
• W1864088770 hasAuthorship W1864088770A5044207347 @default.
• W1864088770 hasAuthorship W1864088770A5056912422 @default.
• W1864088770 hasAuthorship W1864088770A5065550959 @default.
• W1864088770 hasConcept C126322002 @default.
• W1864088770 hasConcept C2776409635 @default.
• W1864088770 hasConcept C2776962512 @default.
• W1864088770 hasConcept C2777396551 @default.
• W1864088770 hasConcept C2777785397 @default.
• W1864088770 hasConcept C2777910003 @default.
• W1864088770 hasConcept C2778677798 @default.
• W1864088770 hasConcept C2778715759 @default.
• W1864088770 hasConcept C2780852908 @default.
• W1864088770 hasConcept C2781276175 @default.
• W1864088770 hasConcept C501593827 @default.
• W1864088770 hasConcept C71924100 @default.
• W1864088770 hasConcept C86803240 @default.
• W1864088770 hasConcept C89423630 @default.
• W1864088770 hasConcept C90924648 @default.
• W1864088770 hasConceptScore W1864088770C126322002 @default.
• W1864088770 hasConceptScore W1864088770C2776409635 @default.
• W1864088770 hasConceptScore W1864088770C2776962512 @default.
• W1864088770 hasConceptScore W1864088770C2777396551 @default.
• W1864088770 hasConceptScore W1864088770C2777785397 @default.
• W1864088770 hasConceptScore W1864088770C2777910003 @default.
• W1864088770 hasConceptScore W1864088770C2778677798 @default.
• W1864088770 hasConceptScore W1864088770C2778715759 @default.
• W1864088770 hasConceptScore W1864088770C2780852908 @default.
• W1864088770 hasConceptScore W1864088770C2781276175 @default.
• W1864088770 hasConceptScore W1864088770C501593827 @default.
• W1864088770 hasConceptScore W1864088770C71924100 @default.
• W1864088770 hasConceptScore W1864088770C86803240 @default.
• W1864088770 hasConceptScore W1864088770C89423630 @default.
• W1864088770 hasConceptScore W1864088770C90924648 @default.
• W1864088770 hasIssue "5" @default.
• W1864088770 hasLocation W18640887701 @default.
• W1864088770 hasLocation W18640887702 @default.
• W1864088770 hasOpenAccess W1864088770 @default.
• W1864088770 hasPrimaryLocation W18640887701 @default.
• W1864088770 hasRelatedWork W1864088770 @default.

• next